Abstract
In eastern Europe, the high prevalence rates of HIV and the hepatitis C virus (HCV) are concentrated among injecting drug users (IDUs). Harm reduction programmes such as needle and syringe programmes and opioid substitution therapy (OST) have been shown to be effective in preventing these infections. However, structural barriers can limit their effectiveness by hindering access.
Original language | English |
---|---|
Journal | Central European Journal of Public Health |
Volume | 17 |
Issue number | 4 |
Pages (from-to) | 191-7 |
Number of pages | 7 |
ISSN | 1210-7778 |
Publication status | Published - 1 Dec 2009 |
Keywords
- Age Factors
- Confidentiality
- Europe, Eastern
- Fees and Charges
- HIV Infections
- Harm Reduction
- Health Services Accessibility
- Hepatitis C
- Humans
- Methadone
- Needle-Exchange Programs
- Pilot Projects
- Prevalence
- Substance Abuse, Intravenous